SCHEMBL103736

SCHEMBL103736

CNC(=O)OC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10810342 1.00 EPHX1 (0.47)
Hydrochloric Acid SCHEMBL28974203 0.97
SCHEMBL21807667 0.91 EPHX1 (0.41)
SCHEMBL12166522 0.91 EPHX1 (0.41)
SCHEMBL12735561 0.91 EPHX1 (0.41)
SCHEMBL14609349 0.91 EPHX1 (0.41)
SCHEMBL966301 0.90 EPHX1 (0.59)
SCHEMBL1752291 0.90
SCHEMBL16230019 0.88 EPHX1 (0.62)
SCHEMBL19312134 0.88 EPHX1 (0.62)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2903979-B1 NOVEL COMPOUNDS, THEIR PREPARATION AND THEIR USES INHIBIKASE THERAPEUTICS INC (US) 2020-08-19 EP claimed
EP-4698224-A1 SAPONIN DERIVATIVES AS ADJUVANTS AND PHOTOAFFINITY PROBES Asociación Centro de Investigación Cooperativa en Biociencias - CIC bioGUNE (ES) 2026-02-25 EP disclosed
WO-2025054361-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2025-03-13 WO disclosed
WO-2024218268-A1 SAPONIN DERIVATIVES AS ADJUVANTS AND PHOTOAFFINITY PROBES ASOCIACIÓN CENTRO DE INVESTIGACIÓN COOPERATIVA EN BIOCIENCIAS-CIC BIOGUNE (ES) 2024-10-24 WO disclosed
EP-4440622-A1 SAPONIN-BASED ADJUVANTS AND VACCINES Asociación Centro de Investigación Cooperativa en Biociencias - CIC bioGUNE (ES) 2024-10-09 EP disclosed
US-12109207-B2 Methods of using 4(1H)-quinolone derivatives ACADEMIA SINICA (TW) 2024-10-08 US disclosed
CN-118638025-A Process for preparing (S) -4, 5-diamino-5-oxopentanoic acid tert-butyl ester 细胞基因公司 2024-09-13 CN disclosed
CN-114736219-B Antitumor compounds 法马马有限公司 2024-06-07 CN disclosed
CN-114751920-B Antitumor compounds 法马马有限公司 2024-06-07 CN disclosed
CN-118055926-A ROCK2 inhibitors and uses thereof 哈佛大学的校长及成员们 2024-05-17 CN disclosed
US-5541229-A ANGIOITENSIN II ANTAGONIST AS HYPOTENSIVE AGENTS, ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS DR. KARL THOMAE GMBH (DE) 1996-07-30 US disclosed
US-5446052-A Used for treatment of substance p-and neurokinin-dependent pathology such as analgesia and inflmmation SANOFI (FR) 1995-08-29 US disclosed
US-5411971-A N-alkylenepiperidino compounds, their enantiomers and pharmaceutical compositions ELF SANOFI (FR) 1995-05-02 US disclosed
US-5300648-A Analgesics, antiinflammatory agents SOCIETE ANONYME: ELF SANOFI (FR) 1994-04-05 US disclosed
US-5254595-A Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them ELF SANOFI (FR) 1993-10-19 US disclosed
US-5236921-A Administrering for treatment of neutrogenic inflammation of the respiratory trart SANOFI (FR) 1993-08-17 US disclosed
EP-0200915-B1 AMINOPROPANOL DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AND MEDICINES CONTAINING THEM Roche Diagnostics GmbH (DE) 1989-09-27 EP disclosed
US-4863949-A CARDIOVASCULAR DISORDER TREATMENT BOEHRINGER MANNHEIM GMBH (DE) 1989-09-05 US disclosed
EP-0280951-A1 Amino-propanol derivatives, process for their preparation and medicines containing these compounds, as well as intermediates Roche Diagnostics GmbH (DE) 1988-09-07 EP disclosed
EP-0200915-A1 Aminopropanol derivatives, process for their preparation, their use and medicines containing them Roche Diagnostics GmbH (DE) 1986-11-12 EP disclosed